NASDAQ · POCI
Healthcare · Medical - Instruments & Supplies
$4.65
Up+$0.06 (+1.31%)
Updated Nov 1, 2026, 7:31 PM
SID Score
4.5/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · POCI
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
POCI closed at $4.65 after 20 trading sessions, up 4.26% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $4.60 | $4.65 | $4.51 | $4.65 | 11.25K |
| Oct 29, 2026 | $4.34 | $4.59 | $4.34 | $4.59 | 20.58K |
| Oct 28, 2026 | $4.44 | $4.44 | $4.335 | $4.34 | 10.99K |
| Oct 27, 2026 | $4.34 | $4.465 | $4.22 | $4.41 | 26.48K |
| Oct 26, 2026 | $4.34 | $4.39 | $4.262 | $4.35 | 17K |
| Oct 23, 2026 | $4.2331 | $4.54 | $4.23 | $4.33 | 16.44K |
| Oct 22, 2026 | $4.32 | $4.32 | $4.22 | $4.23 | 23.9K |
| Oct 21, 2026 | $4.30 | $4.32 | $4.285 | $4.31 | 6.6K |
| Oct 20, 2026 | $4.2655 | $4.3379 | $4.25 | $4.26 | 12.4K |
| Oct 19, 2026 | $4.32 | $4.3314 | $4.26 | $4.27 | 29.93K |
| Oct 16, 2026 | $4.38 | $4.44 | $4.26 | $4.32 | 57.95K |
| Oct 15, 2026 | $4.3703 | $4.41 | $4.32 | $4.35 | 8.56K |
| Oct 14, 2026 | $4.555 | $4.5937 | $4.3102 | $4.41 | 35.77K |
| Oct 13, 2026 | $4.545 | $4.6999 | $4.5101 | $4.56 | 8.09K |
| Oct 12, 2026 | $4.54 | $4.605 | $4.42 | $4.605 | 10.03K |
| Oct 9, 2026 | $4.66 | $4.70 | $4.58 | $4.58 | 14.98K |
| Oct 8, 2026 | $4.46 | $4.74 | $4.435 | $4.665 | 34.52K |
| Oct 7, 2026 | $4.465 | $4.55 | $4.36 | $4.52 | 20.86K |
| Oct 6, 2026 | $4.405 | $4.54 | $4.365 | $4.50 | 15.11K |
| Oct 5, 2026 | $4.51 | $4.51 | $4.375 | $4.46 | 34.42K |
The latest Smart Investors Daily articles mentioning POCI.
Company
Market Activity
Research & News
POCI research
Company profile and research snapshot.
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Yahoo · Sep 29, 2026
Precision Optics Corp Inc (POCI) posted record Q4 revenue of $8.8 million and positive adjusted EBITDA, but flat fiscal 2027 guidance reflects a temporary 40% satellite customer slowdown.
Yahoo · Sep 29, 2026
Moby summary of Precision Optics Corporation, Inc.'s Q4 2026 earnings call
Yahoo · Sep 29, 2026
LITTLETON, Mass., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2026 Investor Conference, taking place virtually on September 29-30, 2026. Company Webcast The webcast presentation will take place at 3:15 p.m. ET on Tuesday, Sep
Yahoo · Sep 29, 2026
Revenue surged 65% to $31.5 million, but satellite demand pauses in 2027.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning POCI.
